期刊文献+

146家医疗机构超说明书用药管理现状调查

Investigation on Management Status of Off-Label Drug Use in 146 Medical Institutions
下载PDF
导出
摘要 目的:了解146家医疗机构超说明书用药的管理现状,为提高超说明书用药管理水平提供参考。方法:通过发放问卷,调查146家医疗机构超说明书用药管理情况,其中三级医院104家,二级医院42家,对基本情况、管理现状、存在的问题、成功经验等方面进行统计分析。结果:146家医疗机构均存在不同程度的超说明书用药,其中125家(占85.62%)开展了超说明书用药管理,管理措施包括建立管理制度(125/125,占100.00%)、制定超说明书用药目录(106/125,占84.80%)、使用过程合理性监管(112/125,占89.60%)等。97.26%(142名)的被调查者认为充分的循证依据是超说明书用药的前提,所在医疗机构超说明书用药证据充分的比例“约50%”的占33.56%(49家),“基本都有”占34.25%(50家),“少数有”占30.14%(44家)。超说明书用药管理面临医师不配合/不重视、不按照规定流程使用(116/146,占79.45%),超说明书现象普遍、难以全面管理(73/146,占50.00%)等问题。超说明书用药管理可采取多部门合作、明确职责,根据循证级别或风险程度分级管理以及引入信息化管理等手段。结论:超说明书现象普遍存在,医疗机构开展超说明书用药管理有一定成效,也面临着困难,应推广成功经验,提升医疗机构超说明书用药管理水平,规范超说明书用药行为。 OBJECTIVE:To investigate the management status of off-label drug use in 146 medical institutions,so as to provide reference for improving the management level of off-label drug use.METHODS:Off-label drug use management in 146 medical institutions was investigated by questionnaire survey,including 104 tertiary hospitals and 42 secondary hospitals.Basic situation,management status,existing problems and successful experience were statistically analyzed.RESULTS:There were different degrees of off-label drug use in 146 medical institutions,of which 125(85.62%)carried out off-label drug use management.The management measures included establishment of management system(125/125,100.00%),formulation of off-label drug use catalogue(106/125,84.80%),and supervision for rationality of use process(112/125,89.60%).Totally 97.26%(142 cases)of the respondents believed that sufficient evidence-based basis was the premise of off-label drug use.The proportion of medical institutions with sufficient evidence of off-label drug use was“about 50%”in 33.56%(49 institutions),“almost all”in 34.25%(50 institutions),and“few”in 30.14%(44 institutions).Off-label drug use management had problems such as clinicians’lack of cooperation/attention,non-use in accordance with prescribed procedures(116/146,79.45%),widespread off-label phenomenon,and difficulty in comprehensive management(73/146,50.00%).Management of off-label drug use can be improved by multi-department cooperation,clear responsibilities,hierarchical management according to the level of evidence or risk,and the introduction of information management.CONCLUSIONS:The phenomenon of off-label drug use is widespread,and medical institutions have made some success in the management of off-label drug use,yet there are also difficulties.Successful experience should be promoted to improve the management level of off-label drug use in medical institutions,so as to standardize the behavior of off-label drug use.
作者 林薇 茅鸯对 马俐丽 于迪 阳丽梅 丁静 LIN Wei;MAO Yangdui;MA Lili;YU Di;YANG Limei;DING Jing(School of Pharmaceutical Business,Zhejiang Pharmaceutical University,Zhejiang Ningbo 315100,China;Dept.of Pharmacy,Ningbo Medical Center of Lihuili Hospital,Zhejiang Ningbo 315100,China;Dept.of Pharmacy,the First Affiliated Hospital of Soochow University,Jiangsu Suzhou 215006,China;Dept.of Pharmacy,Fujian Provincial Hospital/Provincial Clinical Medical College of Fujian Medical University,Fuzhou 350001,China)
出处 《中国医院用药评价与分析》 2024年第5期619-622,626,共5页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 浙江省公益技术研究计划项目(No.LGD19H110001) 浙江省哲学社会科学规划课题(No.20NDJC221YB) 浙江省哲学社会科学规划课题(No.23NDJC446YBM) 浙江省社科联研究课题(No.2024B077)。
关键词 超说明书用药 管理现状 循证证据 知情同意 Off-label drug use Management status Evidence based basis Informed consent
  • 相关文献

参考文献14

二级参考文献98

  • 1张波,李大魁,杨晓.药品说明书之外的用法的若干问题及对策[J].中华风湿病学杂志,2004,8(8):451-453. 被引量:40
  • 2中国药典.二部[S].2010:附录196.
  • 3高文新.依巴斯汀、雷尼替丁联合治疗慢性荨麻疼疗效观察[J].中国皮肢性病学杂志,2005,19(4) :254.
  • 4唐利,惠坤,李承新.EAACI/GA2LEN/EDF/WAO荨麻疹指南[J].中国皮肢性病学杂志,2010,24(9) :871.
  • 5Radley DC, Finkclstein SN, Stafford RS. Off-label prescribing among office-based physicians[ J]. Arch lntern Med, 2006, 166 (9) : 1021-1026.
  • 6Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children [ J ]. BMJ, 2000, 320(7227) : 79-82.
  • 7Herring C, McManus A, Weeks A. Off-label prescribing during pregnancy in the UK:an analysis of 18 000 prescriptions in Liver- pool women's Hospital [ J ]. Int J Pharm Pract, 2010, 18 (4) : 226-229.
  • 8Use of approved drugs for unlabeled indications[J]. Clin Pediatr, 1982, 21(9) : 544.
  • 9ASHP statement on the use of medications for unlabeled uses [J]. Am J Hosp Pharm, 1992, 49(8) : 2006-2008.
  • 10AMERICA SOCIETY OF HOSPITAL PHARMACISTS. ASHP Statement on the use of medications for unlabeled uses. Am J Hosp Pharm, 1992,49(8):2006-2008.

共引文献550

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部